Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis

Allergy and Asthma Proceedings, 05/11/2012

Bepotastine besilate ophthalmic solution (BBOS) 1.5% is safe and effective in the treatment of ocular itching associated with allergic conjunctivitis within 3minutes of a conjunctival allergen challenge (CAC) and with a sustained duration of action of at least 8hours.

Print Article Summary